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The CTG repeat at the 3′ untranslated region of the dystrophia myotonica protein kinase (DMPK) gene shows
marked intergenerational and somatic instability in patients with myotonic dystrophy (DM1), when the repeat is
expanded to more than ∼55 repeats. Intensive research has yielded some insights into the timing and mechanism
of these intergenerational changes: (1) increases in expansion sizes occur during gametogenesis but probably not
during meiosis, (2) the marked somatic mosaicism becomes apparent from the 2nd trimester of development onward
and increases during adult life, and (3) DNA repair mechanisms are involved. We have performed preimplantation
genetic diagnosis for DM1 since 1995, which has given us the unique opportunity to study the expanded CTG
repeat in affected embryos and in gametes from affected patients. We were able to demonstrate signiﬁcant increases
in the number of repeats in embryos from female patients with DM1 and in their immature and mature oocytes,
whereas, in spermatozoa and embryos from male patients with DM1, smaller increases were detected. These data
are in concordance with data on other tissues from adults and fetuses and ﬁll a gap in our knowledge of the
behavior of CTG triplet expansions in DM1.
Myotonic dystrophy (DM1 [MIM 160900]), is a neu-
romuscular disorder with primary symptoms of myo-
tonia and muscle weakness mainly involving facial
muscles and distal muscles of the extremities. Other
symptoms can be cataract; endocrine changes, such as
testicular atrophy; and disruptions of the CNS, such as
increased somnolence, apathy, and even mental retar-
dation in the congenital form of the disease. The mo-
lecular basis of the disease lies in the instability of a
CTG triplet repeat in the 3′ UTR of the DM1 protein
kinase gene (DMPK). In normal individuals, the repeat
size ranges from 3 to 37 repeats, whereas patients with
DM1 exhibit expansions of 150 repeats and, often, as
many as several thousand repeats in the congenital form
of the disease (Brook et al. 1992). Expanded CTG re-
peats are unstable and usually increase in number in
successive generations. In DM1, an aggravation of symp-
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toms (called “anticipation”) from asymptomatic to overt
DM1 is found often when transmitted through the fa-
ther, whereas children with the severe congenital form
of the disease are born almost exclusively to affected
mothers (Harper and Johnson 2001). In somatic cells,
a high level of mosaicism can be detected also, depending
on the patient’s age and repeat number (Monckton et
al. 1995; Wong et al. 1995) and on the tissues exam-
ined—repeat expansions are found to be smallest in
blood and largest in heart, muscle, and kidney (Jansen
et al. 1994; Martorell et al. 1997).
Currently, the working hypothesis is that the insta-
bility may occur at different stages of DNA interactions,
such as DNA replication before meiosis, double-strand
break formation during meiosis, and DNA repair after
meiosis (Pearson et al. 2002, 2003; Sinden et al. 2002).
Little information is available, about the stability of tri-
nucleotide repeats in human early embryos and in female
gametes, that can conﬁrm these hypotheses. At our cen-
ter, preimplantation genetic diagnosis (PGD) for DM1
has been done since 1995 (Sermon et al. 2001). This has
given us the unique opportunity to study female gametes
and preimplantation embryos shown to be affected after
PGD and donated for research by the patients, thus en-
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abling us to close the gap left by the analysis of blood
and offspring.
Blood, gametes, and embryos were analyzed from 32
different patients. The mean age of the patients with
DM1 at PGD was 31.4 years. The local medical ethics
committee approved this study, and patients signed an
informed consent. PGDwas performed as described else-
where (Sermon et al. 2001).
Spermatozoa from patients with DM1 were collected
either in groups of 10 or 20 cells or as single cells by
micromanipulation. The zona pellucida of the germinal
vesicle (GV), metaphase I (MI) and mature metaphase
II (MII) oocytes with their polar bodies, and research
embryos were removed with the use of acidic Tyrode
solution. Embryos that were unsuitable for biopsy at day
3 were collected, as well as embryos shown to be affected
after PGD and embryos shown to be unaffected after PGD
that were unsuitable for transfer or cryopreservation as
a result of bad morphology. All samples were collected
in 0.2-ml tubes containing alkaline lysis buffer (200 mM
of KOH or NaOH and 50 mM of dithiothreitol).
A speciﬁc PCR for long fragments, followed by South-
ern blot analysis, was performed on the samples to
visualize the expansions. However, because the small al-
leles could not be discriminated, a ﬂuorescent second-
round PCR, with the PCR product of the long PCR as
a template, was performed and was followed by analysis
on an automated DNA sequencer (ALFExpress, Amer-
sham Pharmacia Biotech). Together with each set of
gametes or embryos, 100 pg of the DNA from parents
affected with DM1 was ampliﬁed for comparison. Both
PCRs were performed using the Expand Long Template
system (Roche Diagnostics), with 0.3 mM of primers
DM101 and DM102 (Brook et al. 1992) and in accor-
dance with the manufacturer’s instructions.
PCR fragments were separated either on a regular
nondenaturing agarose gel or, owing to the occurrence
of heteroduplexes, on a denaturing alkaline agarose gel
(Sambrook and Russell 2001). After Southern blot, the
nylon membrane was hybridized to the digoxigenin-
labeled (CAG)5 probe (Eurogentec) and was processed
further with the use of the DIG-CSPD system (Roche
Diagnostics), in accordance with the manufacturers’
recommendations.
As determined by Martorell et al. (2000), the “true
germline change” is the difference between the smallest
measured allele in blood DNA of the affected parent
(i.e., the affected gene present in the sperm or oocyte
that, after fertilization, gave rise to the affected patient
who later came to us for PGD treatment) and the ex-
pansion measured in the gamete or embryo. The mean
size of the smallest expanded band in the DNA of our
patient group was 133.5 repeats for all 32 patients:
133.9 repeats for the 22 female patients (range 42–468
repeats) and 132.6 repeats for the 10 male patients
(range 62–256 repeats).
Gametes and embryos from 64 PGD cycles were an-
alyzed. These 64 cycles were performed for 32 patients:
48 were for the 22 female patients, and 16 were for the
10 male patients.
Because of the limited amount of data obtained from
ejaculated sperm and the high interpatient variability
(Martorell et al. 2000), great care must be taken in draw-
ing conclusions from this group. The average germline
change in sperm that showed an expansion was 55.9
repeats, and the highest repeat number detected was 329
repeats, which gave a germline change of 186 repeats.
In total, 18 spermatozoa showed a reduction, with an
average change of 41.1 repeats, whereas the repeat
remained stable in 13 spermatozoa. The behavior of the
triplet repeat in spermatozoa and its relation to the re-
peat of the progenitor agree with what has been de-
scribed in the literature (Jansen et al. 1994; Monckton
et al. 1995; Martorell et al. 2000): signiﬁcant but not
extensive enlargements were detected in spermatozoa of
patients with small expansions. Also, a larger number
of contractions were detected in spermatozoa and em-
bryos from affected males than in oocytes and embryos
from affected females. Because of the extensive data al-
ready existing in literature, only a few cells were tested.
A total of 56 oocytes were analyzed. In the GV oo-
cytes, 3 (of 15) showed an expansion, and the average
germline change was 337.0 repeats, with a maximal
enlargement of 404 repeats. Of the MI oocytes, 8 (of
25) showed an expansion, and the average germline
change was 401.1 repeats, with a maximal enlarge-
ment of 950 repeats. The average germline change for
the 11 (of 16) MII oocytes was 332.2 repeats, with
the largest enlargement being 614 repeats.
Of the 144 embryos, 77 (53%) were diagnosed as
affected during PGD, and 92 (39%) of the 236 non-
biopsied embryos showed an expansion of the repeat
(ﬁg. 1). The increase in the size of the repeat in oocytes
and embryos from female patients was larger; again, this
was in agreement with the literature. The largest ex-
pansion we could detect was 1,372 repeats (compared
with369 repeats, the largest repeat number in samples
from males), though the largest expansions were prob-
ably missed because of the limitation of the ampliﬁcation
procedure and the possible deterioration of DNA in the
cells.
The ampliﬁcation rate of expanded alleles was rather
low for the oocytes (39%), nonbiopsied embryos (39%),
and affected embryos (53%). The low ampliﬁcation ef-
ﬁciency in the oocytes can be explained by the fact that
these are abnormal, and possibly dying, cells. In the case
of the nonbiopsied embryos, this can be explained par-
tially by the fact that approximately half of the embryos
are, in fact, healthy, but this does not hold true for the
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Figure 1 CTG instability in 346 samples from patients with DM1. Each bar represents the germline change in one sample, either an
oocyte, spermatozoon, or embryo. The samples on the left are from female patients (blackened boxes and checkered boxes), and the samples
on the right are from male patients (grid boxes and unblackened boxes). The germline change is the difference between the smallest band
detected in blood DNA of the parent and the size of the repeat in the embryos, oocytes, or spermatozoa.
affected embryos. These ﬁndings mainly illustrate the
limits of our PCR assay to detect larger expansions and
may be explained by the fact that some of the embryos
were already degenerated at the moment of analysis.
No mosaicism was detected in any of the affected
embryos. These data agree with earlier results showing
that somatic mosaicism in affected fetuses starts only
during the 2nd trimester of gestation (Jansen et al. 1994;
Martorell et al. 1997).
In table 1, a summary is given of the germline changes
measured in all spermatozoa, oocytes, and embryos after
maternal or paternal transmission. Because of the limited
number of oocytes, only a general trend can be deduced
from this data set. The difference in range of instability
of the triplet repeat after paternal and maternal trans-
mission is remarkable. Not only is the range of instability
nearly 10 times larger after maternal transmission, but
more contractions of the repeat number also occur (ﬁg.
1) after paternal transmission. Because of the small sam-
ple size, these differences are not statistically signiﬁcant
( , x2 test).Pp .1046
The exceptional availability of post-PGD material al-
lowed us to investigate immature and mature oocytes.
Although the oocyte sample is too small to draw deﬁnite
conclusions, our results indicate that enlargement of the
repeat had occurred at the GV stage, that is, either during
premeiotic proliferation of oogonia or during prophase
I of meiosis I. Several models exist to explain the insta-
bility of triplet repeats during DNA replication (Cleary
et al. 2002; Yang et al. 2003). Other models mainly focus
on the appearance of errors in the DNA repair; several
publications suggest that the DNA repair mechanism
(mismatch repair system or MMR) plays an important
role in the instabilities of the triplet repeats (Pearson et
al. 1997; van den Broek et al. 2002; Savouret et al.
2003). This agrees with the ﬁndings of Kaytor et al.
(1997), who examined the behavior of a spinocerebellar
ataxia type I (SCA1, another neurodegenerative disorder
caused by a dynamic mutation) cDNA containing a CTG
trinucleotide repeat tract introduced into transgenic
mice. Those authors hypothesized that, in oocytes, in-
stability of the triplet repeat occurs while the oocytes
are arrested in meiosis I after meiotic DNA replication.
However, the timing of the expansion instability con-
trasts with the ﬁndings of Kovtun and McMurray
(2001), who concluded from their investigation of sper-
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Table 1
Germline Change for Samples with an Enlarged Repeat Number after Maternal and Paternal Transmission
TRANSMISSION TYPE
AND STATISTIC
RESULT IN
Embryos Oocytes
Spermatozoa All2PNa Cleavageb Compactc Blastocyst
Immature
Oocytesd
MII
Oocytese
Maternal:
N 15 89 17 2 11 11 … 145
Average germline change 288.2 308.8 232.6 919.5 383.6 332.2 … 313.6
Maximum germline change 1,014 1,085 1,281 1,067 950 614 … 1,281
Minimum germline change 10 42 180 772 121 108 … 180
No. of contractions 1 9 2 0 0 0 … 12
Paternal:
N 5 51 11 8 … … 126 201
Average germline change 118.0 100.3 35.2 46.2 … … 55.9 68.1
Maximum germline change 179 210 114 186 … … 186 210
Minimum germline change 86 81 85 208 … … 81 208
No. of contractions 1 3 2 2 … … 18 28
NOTE.—The germline change is deﬁned as the difference between the smallest measured allele in blood DNA of the affected parent
(i.e., the allele in the gamete at the origin of the parent carrying the mutation) and the expansion measured in the gamete or embryo
(Martorell et al. 2000).
a Pronuclear single-cell embryo (2PN p two pronuclei).
b Embryos arrested at the cleavage stage (from 2-cellular to 10-cellular cleavage stage embryos).
c Embryos arrested at the compacted stage (112 cells).
d The immature oocytes include oocytes at the GV stage and oocytes arrested at the MI stage.
e The mature MII oocytes are MII oocytes not suitable for microinjection.
matozoa from mice transgenic for the exon 1 of the
human Huntington disease (HD) gene that expansion
arises in the haploid stage of spermatozoa development,
by gap repair. Yoon et al. (2003) could detect expansions
in the HD locus in premeiotic and postmeiotic human
male germ cells, leading those authors to conclude that
the long lifespan and lifelong cell division of postpub-
ertal spermatogonial stem cells make them likely targets
for age-dependent mutations that arise by DNA damage
repair or by cell-division–dependent DNA replication
errors, respectively. This hypothesis was expanded fur-
ther by Pearson (2003) to the female germ line, where
the emphasis would be on DNA repair, owing to the
limited number of cell divisions undergone by the female
germ line. Our ﬁnding that expansion has occurred al-
ready in immature oocytes before completion of meiosis
would, indeed, implicate DNA repair in these cells that
have undergone a long period of quiescence. The dif-
ferences in timing and/or mechanism could also account
for the differences observed in transmission of the ex-
pansion between males and females. Further study of
immature sperm progenitors—for example, in testicular
biopsies from patients with DM1 undergoing PGD—as
well as in earlier stages of female gametes, should shed
more light on this question.
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